Portal de Periódicos da CAPES

Artigo Produção Nacional Revisado por pares

BIBTEX RIS

8‐Hydroxyquinoline‐5‐sulfonamides are promising antifungal candidates for the topical treatment of dermatomycosis

2019; Oxford University Press; Volume: 128; Issue: 4 Linguagem: Inglês

10.1111/jam.14545

1365-2672

Bruna Pippi, Angélica Rocha Joaquim, William Lopes, Gabriella da Rosa Monte Machado, Vanessa Zafaneli Bergamo, Laura Giuliani, Maxwel Adriano Abegg, Letícia Cruz, Marilene Henning Vainstein, Alexandre Meneghello Fuentefría, Saulo Fernandes de Andrade,

Nail Diseases and Treatments

The purpose of this study was to uncover insights into the mechanism of action of the 8-hydroxyquinoline derivatives PH151 and PH153. In addition, with the future perspective of developing a topical drug for the treatment of candidiasis and dermatophytosis, the antifungal activity of a nanoemulsion formulation containing the most active compound (PH151) is also presented here.Sorbitol protection assay and scanning electron microscopy indicate that the 8-hydroxyquinoline derivatives act on the cell wall of Candida sp. and dermatophytes and they inhibit the pseudohyphae formation of C. albicans. These findings demonstrate a strong effect of these compounds on C. albicans morphogenesis, which can be considered a potential mode of action for this molecule. Besides, the nanoemulsion formulation MIC values ranged from 0·5 to 4 μg ml-1 demonstrating the significant antifungal activity when incorporated into a pharmaceutical formulation.Taken together, the results support the potential of these molecules as promising antifungal candidates for the treatment of candidiasis and dermatophytosis.There is an emerging need to fill the pipeline with new antifungal drugs due to the limitations presented by the currently used drugs. In this study, we have described a novel formulation with a 8-hydroxyquinoline-5-sulfonamide derivative which has presented a great potency in providing a finished product. Furthermore, the derivative has shown a selective mechanism of action confirming its potential to be developed into a new drug candidate.